PL424871A1 - Application of copolymers for production of a preparation intended for treatment and prevention of diseases induced by HSV-1 virus - Google Patents

Application of copolymers for production of a preparation intended for treatment and prevention of diseases induced by HSV-1 virus

Info

Publication number
PL424871A1
PL424871A1 PL424871A PL42487118A PL424871A1 PL 424871 A1 PL424871 A1 PL 424871A1 PL 424871 A PL424871 A PL 424871A PL 42487118 A PL42487118 A PL 42487118A PL 424871 A1 PL424871 A1 PL 424871A1
Authority
PL
Poland
Prior art keywords
hsv
virus
prevention
treatment
copolymers
Prior art date
Application number
PL424871A
Other languages
Polish (pl)
Other versions
PL235423B1 (en
Inventor
Maria Nowakowska
Krzysztof PYRĆ
Krzysztof SZCZUBIAŁKA
Magdalena PACHOTA
Original Assignee
Uniwersytet Jagielloński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagielloński filed Critical Uniwersytet Jagielloński
Priority to PL424871A priority Critical patent/PL235423B1/en
Priority to PCT/PL2019/050015 priority patent/WO2019177475A1/en
Priority to DE112019001290.8T priority patent/DE112019001290T5/en
Publication of PL424871A1 publication Critical patent/PL424871A1/en
Publication of PL235423B1 publication Critical patent/PL235423B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyethers (AREA)

Abstract

Zgłoszenie dotyczy zastosowania kopolimerów blokowych o łańcuchach złożonych z bloku poli(glikolu etylenowego) (PEG) i bloku poli(chlorku(3-(metakryloiloamino)propylo)trimetyloamoniowego) (PMAPTAC) do wytwarzania preparatu do leczenia i profilaktyki chorób wywoływanych przez wirusa HSV-1.The application relates to the use of block copolymers with chains composed of poly (ethylene glycol) (PEG) block and poly ((3- (methacryloylamino) propyl) trimethyl ammonium chloride (PMAPTAC) block for the preparation of a preparation for the treatment and prevention of diseases caused by HSV-1 virus. .

PL424871A 2018-03-13 2018-03-13 Application of copolymers for production of a preparation intended for treatment and prevention of diseases induced by HSV-1 virus PL235423B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL424871A PL235423B1 (en) 2018-03-13 2018-03-13 Application of copolymers for production of a preparation intended for treatment and prevention of diseases induced by HSV-1 virus
PCT/PL2019/050015 WO2019177475A1 (en) 2018-03-13 2019-03-13 The use of copolymers for the preparation of a formulation for the treatment and prophylaxis of diseases caused by the hsv-1 virus
DE112019001290.8T DE112019001290T5 (en) 2018-03-13 2019-03-13 Use of copolymers for the manufacture of a formulation for the treatment and prophylaxis of diseases caused by the HSV-1 virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL424871A PL235423B1 (en) 2018-03-13 2018-03-13 Application of copolymers for production of a preparation intended for treatment and prevention of diseases induced by HSV-1 virus

Publications (2)

Publication Number Publication Date
PL424871A1 true PL424871A1 (en) 2019-09-23
PL235423B1 PL235423B1 (en) 2020-07-27

Family

ID=67906855

Family Applications (1)

Application Number Title Priority Date Filing Date
PL424871A PL235423B1 (en) 2018-03-13 2018-03-13 Application of copolymers for production of a preparation intended for treatment and prevention of diseases induced by HSV-1 virus

Country Status (3)

Country Link
DE (1) DE112019001290T5 (en)
PL (1) PL235423B1 (en)
WO (1) WO2019177475A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL249275B1 (en) * 2022-07-17 2026-03-16 Univ Jagiellonski Cationic polymer with antifungal properties

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL412654A1 (en) * 2015-06-10 2016-12-19 Uniwersytet Jagielloński Adaptation of block polymer containing the block of poly(3-(methacryloylamino)propyltrimethyloammonium chloride (PMAPTAC) for neutralization of heparin
PL416749A1 (en) * 2016-04-04 2017-10-09 Uniwersytet Jagielloński Application of cationic derivative of dextrane for retardation of HSV-1 viral replication

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015082172A1 (en) * 2013-12-03 2015-06-11 Zzip Ag Polydimethylsiloxane for the treatment of viral infections

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL412654A1 (en) * 2015-06-10 2016-12-19 Uniwersytet Jagielloński Adaptation of block polymer containing the block of poly(3-(methacryloylamino)propyltrimethyloammonium chloride (PMAPTAC) for neutralization of heparin
PL416749A1 (en) * 2016-04-04 2017-10-09 Uniwersytet Jagielloński Application of cationic derivative of dextrane for retardation of HSV-1 viral replication

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SAHOO SATYAGOPAL, WATER-SOLUBLE NANOPARTIDES FRAM PEGYLATED LINEAR A CATIONIC BLOCK COPOLYMERS AND ANIONIE SURFAETANTS, 22 November 2017 (2017-11-22) *

Also Published As

Publication number Publication date
WO2019177475A1 (en) 2019-09-19
PL235423B1 (en) 2020-07-27
DE112019001290T5 (en) 2021-03-11

Similar Documents

Publication Publication Date Title
CY1125144T1 (en) PHARMACEUTICAL COMPOSITION, METHODS OF THERAPY AND USE THEREOF
CY1125214T1 (en) N-((ET)ARYLMETHYL)-HETEROARYL-CARBOXAMIDE COMPOUNDS AS PLASMA KALLIKREIN INHIBITORS
CY1120950T1 (en) FIBER TREATMENT
CY1125505T1 (en) OPHTHALMIC COMPOSITIONS WHICH COMPRISE A MUSCARINIC ANTAGONIST AND DEUTIATED HYDROCHLORIDE
CY1125089T1 (en) METHODS FOR THE TREATMENT OF CORONAVIRIDAE INFECTIONS
MX387115B (en) METHODS FOR TREATING INFLUENZA.
EA201791576A1 (en) JAK INHIBITOR
EA201691726A1 (en) NEW 6-CONDENSED HETEROARYDYDYDROPYRIMIDIDES FOR THE TREATMENT AND PREVENTION OF HEPATITIS B VIRUS INFECTION
EA201792116A1 (en) JANUS KINASE INHIBITOR
NZ780244A (en) Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
EA201691624A1 (en) Heterocyclic Compound
PH12017550023A1 (en) A modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders
BR112017026061A2 (en) compound, use of a compound, and method of treating a viral infection
CY1124596T1 (en) PHARMACEUTICAL COMPOSITION OF TRAMADOL FOR OPHTHALMIC USE
EA201891440A1 (en) COMPOSITIONS / COMPOSITIONS CONTAINING BTK INHIBITOR
EA201991253A1 (en) BENZODIAZOLIUM COMPOUNDS AS ENAC INHIBITORS
EA201790507A1 (en) METHODS AND COMPOSITIONS FOR STRENGTHENING IMMUNE RESPONSES
EA201891740A1 (en) [BIS (TRIHIDROKARBILSILIL) AMINOSILYL] -FUNCTIONALIZED STYRENE AND METHOD FOR ITS PREPARATION
CY1122374T1 (en) BIOTIN FOR THE THERAPEUTIC TREATMENT OF DEMYELINOTIC NEUROPATHIES
CY1121566T1 (en) NEUROPROTECTIVE AND INDICATION OF THIS
MX2022000811A (en) ENZYME INHIBITORS.
MX2021000542A (en) SOLUBILIZED APIRASES, METHODS AND USES.
WO2016029136A8 (en) 3-amidobenzamides and uses thereof for increasing cellular levels of a3g
EA201890653A1 (en) COMPOSITION WITH ANTI-VIRAL EFFECT
PL424871A1 (en) Application of copolymers for production of a preparation intended for treatment and prevention of diseases induced by HSV-1 virus